Document Detail


Effect of long-chain polyunsaturated fatty acid supplementation of preterm infants on disease risk and neurodevelopment: a systematic review of randomized controlled trials.
MedLine Citation:
PMID:  18400714     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Supplementation of preterm formulas with long-chain polyunsaturated fatty acids (LCPUFAs) is based on their effectiveness to increase blood status and improve visual outcomes. Dispute remains over their efficacy on global development. OBJECTIVE: The objective was to compare the effects of LCPUFA-supplemented with those of control formulas on neurodevelopment and diseases associated with prematurity. DESIGN: We systematically reviewed randomized controlled trials involving preterm infants that tested LCPUFA-supplemented formulas. The weighted mean differences (WMDs) in neurodevelopmental scores and relative risk (RR) of disease were calculated to compare infants fed LCPUFA-supplemented formula with those fed control formula. RESULTS: No clear differences in Bayley Scales of Infant Development (BSID) scores were observed between groups. Mental development of LCPUFA-supplemented infants was 3.4 points higher than that of control infants with BSID version II (WMD: 3.44; 95% CI: 0.56, 6.31; P = 0.02; n = 879), although it was driven by 2 trials with large effect sizes and wide CIs. Psychomotor development was lower in supplemented infants tested with BSID version I (WMD: -7.99; 95% CI: -14.00, -1.99; P = 0.009; n = 87); however, it was limited by small sample sizes. No differences in the RR of sepsis (1.08; 95% CI: 0.79, 1.46; P = 0.63; n = 1333) or in the RR of necrotizing enterocolitis (1.13; 95% CI: 0.62, 2.04; P = 0.69; n = 1333) were found. Similarly, the risks of retinopathy of prematurity, intraventricular hemorrhage, and bronchopulmonary dysplasia were not different between groups, but data were limited by small sample sizes and trials with an increased risk of bias. CONCLUSIONS: LCPUFA-supplemented formula does not alter the risk of NEC or sepsis. Further work is needed to determine the extent of benefit of LCPUFA-supplemented formula on the mental development of preterm infants.
Authors:
Lisa G Smithers; Robert A Gibson; Andrew McPhee; Maria Makrides
Related Documents :
7472904 - Effect of a fermented infant formula containing viable bifidobacteria on the fecal flor...
20726584 - Development and application of an hilic-ms/ms method for the quantitation of nucleotide...
19543114 - Randomized controlled trial of feeding a concentrated formula to infants born to women ...
9651424 - Neonatal circumcision: when can infants reliably be expected to void?
18452944 - Learning by looking: infants' social looking behavior across the transition from crawli...
15655314 - Effect of two amino acid solutions on leucine turnover in preterm infants.
Publication Detail:
Type:  Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  The American journal of clinical nutrition     Volume:  87     ISSN:  1938-3207     ISO Abbreviation:  Am. J. Clin. Nutr.     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-04-10     Completed Date:  2008-04-28     Revised Date:  2009-05-15    
Medline Journal Info:
Nlm Unique ID:  0376027     Medline TA:  Am J Clin Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  912-20     Citation Subset:  AIM; IM    
Affiliation:
Child Health Research Institute, Child, Youth and Women's Health Service, North Adelaide, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Child Development / drug effects*,  physiology
Cognition / drug effects
Dietary Supplements
Fatty Acids, Unsaturated / administration & dosage,  metabolism,  pharmacology*
Female
Humans
Infant
Infant Formula / chemistry*
Infant Nutritional Physiological Phenomena / physiology*
Infant, Newborn
Infant, Premature / growth & development*
Male
Mental Health
Nutritional Status*
Randomized Controlled Trials as Topic
Risk Factors
Sepsis / epidemiology
Visual Acuity / drug effects
Chemical
Reg. No./Substance:
0/Fatty Acids, Unsaturated

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Genetic and shared environmental influences on children's 24-h food and beverage intake: sex differe...
Next Document:  Effects of alpha-lactalbumin-enriched formula containing different concentrations of glycomacropepti...